photo of

Details

Role Team Leader / Senior Research Officer

Contact

Available for student supervision
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the...
Dr Messina is a Team Leader in the MCRI Infectious Diseases research group where she currently leads the immunology research program with a focus on the clinical and immunological off-target effects of vaccines. Dr Messina completed her PhD at the Peter MacCallum Cancer Centre investigating crosstalk in cytokine signalling pathways and the role of interferon signalling pathways in tumour immunosurveillance. Her previous research has also included investigating the role of cytokine response pathways in regulatory T cell development and function. Dr Messina co-supervises four PhD students, holds an Honorary Research Fellow appointment with the University of Melbourne and is a member of the Melbourne Children's Graduate Research Committee and MCRI animal ethics committee.

Top Publications

  • Pittet, LF, Messina, NL, Gardiner, K, Freyne, B, Abruzzo, V, Morrison, C, Vuillermin, P, Allen, KJ, Ponsonby, A-L, Robins-Browne, R, et al. Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials. Dermatitis 33(3) : 207 -214 2022
    view publication
  • Pittet, LF, Fritschi, N, Tebruegge, M, Dutta, B, Donath, S, Messina, NL, Casalaz, D, Hanekom, WA, Britton, WJ, Robins-Browne, R, et al. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.. American Journal of Respiratory and Critical Care Medicine 205(7) : 830 -841 2022
    view publication
  • Pittet, LF, Messina, NL, Gardiner, K, Freyne, B, Abruzzo, V, Francis, KL, Morrison, C, Zufferey, C, Vuillermin, P, Allen, KJ, et al. Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial. Allergy 77(3) : 956 -965 2022
    view publication
  • Pittet, LF, Cox, L, Freyne, B, Germano, S, Bonnici, R, Gardiner, K, Donath, S, Collins, CL, Casalaz, D, Robins-Browne, R, et al. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner. Vaccine 40(9) : 1334 -1341 2022
    view publication
  • Messina, NL, Germano, S, McElroy, R, Rudraraju, R, Bonnici, R, Pittet, LF, Neeland, MR, Nicholson, S, Subbarao, K, Curtis, N, et al. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19. Clinical & Translational Immunology 11(4) : e1387 2022
    view publication

Page 5 of 12